Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Monsó E[au]:

The microbiome in respiratory medicine: current challenges and future perspectives. Faner R et al. Eur Respir J. (2017)

Microbiome in chronic obstructive pulmonary disease. Monsó E et al. Ann Transl Med. (2017)

Multi-level differential network analysis of COPD exacerbations. Noell G et al. Eur Respir J. (2017)

Search results

Items: 1 to 50 of 156

1.

The BIOMEPOC Project: Personalized Biomarkers and Clinical Profiles in Chronic Obstructive Pulmonary Disease.

Gea J, Pascual S, Castro-Acosta A, Hernández-Carcereny C, Castelo R, Márquez-Martín E, Montón C, Palou A, Faner R, Furlong LI, Seijo L, Sanz F, Torà M, Vilaplana C, Casadevall C, López-Campos JL, Monsó E, Peces-Barba G, Cosío BG, Agustí A; en representación del grupo BIOMEPOC; Anexo. Miembros del grupo BIOMEPOC.

Arch Bronconeumol. 2018 Oct 18. pii: S0300-2896(18)30329-6. doi: 10.1016/j.arbres.2018.07.026. [Epub ahead of print] English, Spanish.

2.

Tumor-associated metabolic and inflammatory responses in early stage non-small cell lung cancer: Local patterns and prognostic significance.

Millares L, Barreiro E, Cortes R, Martinez-Romero A, Balcells C, Cascante M, Enguita AB, Alvarez C, Rami-Porta R, Sánchez de Cos J, Seijo L, Monsó E; Grupo Colaborativo en Cáncer de Pulmón CIBERES- CIBERONC- SEPAR - Plataforma Biobanco Pulmonar.

Lung Cancer. 2018 Aug;122:124-130. doi: 10.1016/j.lungcan.2018.06.015. Epub 2018 Jun 10.

PMID:
30032820
3.

A novel protein-based prognostic signature improves risk stratification to guide clinical management in early-stage lung adenocarcinoma patients.

Martínez-Terroba E, Behrens C, de Miguel FJ, Agorreta J, Monsó E, Millares L, Sainz C, Mesa-Guzman M, Pérez-Gracia JL, Lozano MD, Zulueta JJ, Pio R, Wistuba II, Montuenga LM, Pajares MJ.

J Pathol. 2018 Aug;245(4):421-432. doi: 10.1002/path.5096. Epub 2018 Jun 20.

PMID:
29756233
4.

Population structure of Environmental and Clinical Legionella pneumophila isolates in Catalonia.

Quero S, Párraga-Niño N, Barrabeig I, Sala MR, Pedro-Botet ML, Monsó E, Jané M, Sabrià M, Garcia-Núñez M.

Sci Rep. 2018 Apr 19;8(1):6241. doi: 10.1038/s41598-018-24708-1.

5.

Clinical and Safety Outcomes of Long-Term Azithromycin Therapy in Severe COPD Beyond the First Year of Treatment.

Pomares X, Montón C, Bullich M, Cuevas O, Oliva JC, Gallego M, Monsó E.

Chest. 2018 May;153(5):1125-1133. doi: 10.1016/j.chest.2018.01.044. Epub 2018 Feb 7.

PMID:
29427576
6.

Specific IgA against Pseudomonas aeruginosa in severe COPD.

Millares L, Martí S, Ardanuy C, Liñares J, Santos S, Dorca J, García-Nuñez M, Quero S, Monsó E.

Int J Chron Obstruct Pulmon Dis. 2017 Sep 30;12:2807-2811. doi: 10.2147/COPD.S141701. eCollection 2017.

7.

Multi-level differential network analysis of COPD exacerbations.

Noell G, Cosío BG, Faner R, Monsó E, Peces-Barba G, de Diego A, Esteban C, Gea J, Rodriguez-Roisin R, Garcia-Nuñez M, Pozo-Rodriguez F, Kalko SG, Agustí A.

Eur Respir J. 2017 Sep 27;50(3). pii: 1700075. doi: 10.1183/13993003.00075-2017. Print 2017 Sep.

PMID:
28954781
8.

Effect of a rehabilitation-based chronic disease management program targeting severe COPD exacerbations on readmission patterns.

Lalmolda C, Coll-Fernández R, Martínez N, Baré M, Teixidó Colet M, Epelde F, Monsó E.

Int J Chron Obstruct Pulmon Dis. 2017 Aug 23;12:2531-2538. doi: 10.2147/COPD.S138451. eCollection 2017.

9.

Microbiome in chronic obstructive pulmonary disease.

Monsó E.

Ann Transl Med. 2017 Jun;5(12):251. doi: 10.21037/atm.2017.04.20. Review.

10.

The microbiome in respiratory medicine: current challenges and future perspectives.

Faner R, Sibila O, Agustí A, Bernasconi E, Chalmers JD, Huffnagle GB, Manichanh C, Molyneaux PL, Paredes R, Pérez Brocal V, Ponomarenko J, Sethi S, Dorca J, Monsó E.

Eur Respir J. 2017 Apr 12;49(4). pii: 1602086. doi: 10.1183/13993003.02086-2016. Print 2017 Apr. Review.

11.

Bronchial microbiome, PA biofilm-forming capacity and exacerbation in severe COPD patients colonized by P. aeruginosa.

Garcia-Nuñez M, Marti S, Puig C, Perez-Brocal V, Millares L, Santos S, Ardanuy C, Moya A, Liñares J, Monsó E.

Future Microbiol. 2017 Apr;12:379-392. doi: 10.2217/fmb-2016-0127. Epub 2017 Mar 24.

PMID:
28339291
12.

The respiratory microbiome in bronchial mucosa and secretions from severe IgE-mediated asthma patients.

Millares L, Bermudo G, Pérez-Brocal V, Domingo C, Garcia-Nuñez M, Pomares X, Moya A, Monsó E.

BMC Microbiol. 2017 Jan 19;17(1):20. doi: 10.1186/s12866-017-0933-6.

13.

The respiratory microbiome: Beyond the culture.

Monsó E.

Arch Bronconeumol. 2017 Sep;53(9):473-474. doi: 10.1016/j.arbres.2016.11.008. Epub 2017 Jan 6. English, Spanish. No abstract available.

14.

FDG-PET parameters predicting mediastinal malignancy in lung cancer.

Serra Fortuny M, Gallego M, Berna L, Montón C, Vigil L, Masdeu MJ, Fernández-Villar A, Botana MI, Cordovilla R, García-Luján R, Cases E, Monsó E.

BMC Pulm Med. 2016 Dec 8;16(1):177.

15.

C-reactive protein in outpatients with acute exacerbation of COPD: its relationship with microbial etiology and severity.

Gallego M, Pomares X, Capilla S, Marcos MA, Suárez D, Monsó E, Montón C.

Int J Chron Obstruct Pulmon Dis. 2016 Oct 21;11:2633-2640. eCollection 2016.

16.

Aberrant gene methylation and bronchial dysplasia in high risk lung cancer patients.

Rosell A, Rodríguez N, Monsó E, Taron M, Millares L, Ramírez JL, López-Lisbona R, Cubero N, Andreo F, Sanz J, Llatjós M, Llatjós R, Fernández-Figueras MT, Mate JL, Català I, Setó L, Roset M, Díez-Ferrer M, Dorca J.

Lung Cancer. 2016 Apr;94:102-7. doi: 10.1016/j.lungcan.2016.02.003. Epub 2016 Feb 11.

PMID:
26973214
17.

Lack of Correlation Between Pulmonary and Systemic Inflammation Markers in Patients with Chronic Obstructive Pulmonary Disease: A Simultaneous, Two-Compartmental Analysis.

Núñez B, Sauleda J, Garcia-Aymerich J, Noguera A, Monsó E, Gómez F, Barreiro E, Marín A, Antó JM, Agusti A; Miembros del Grupo de Trabajo sobre la Caracterización Fenotípica y Evolución de la EPOC (PAC-COPD).

Arch Bronconeumol. 2016 Jul;52(7):361-7. doi: 10.1016/j.arbres.2016.01.003. Epub 2016 Feb 24. English, Spanish.

18.

Functional Metagenomics of the Bronchial Microbiome in COPD.

Millares L, Pérez-Brocal V, Ferrari R, Gallego M, Pomares X, García-Núñez M, Montón C, Capilla S, Monsó E, Moya A.

PLoS One. 2015 Dec 3;10(12):e0144448. doi: 10.1371/journal.pone.0144448. eCollection 2015.

19.

Assessment of methylation status of locoregional lymph nodes in lung cancer using EBUS-NA.

Millares L, Serra M, Andreo F, Sanz-Santos J, Montón C, Grimau C, Gallego M, Setó L, Combalia N, Llatjos M, Escoda R, Castellà E, Monsó E.

Clin Exp Metastasis. 2015 Oct;32(7):637-46. doi: 10.1007/s10585-015-9733-2. Epub 2015 Jun 29.

PMID:
26119430
20.

Glucocorticoids and antibiotics, how do they get together?

Reidl J, Monsó E.

EMBO Mol Med. 2015 Aug;7(8):992-3. doi: 10.15252/emmm.201505336.

21.

Reply to "chronic obstructive pulmonary disease lung microbiota diversity may be mediated by age or inhaled corticosteroid use".

Garcia-Nuñez M, Millares L, Pomares X, Ferrari R, Pérez-Brocal V, Gallego M, Espasa M, Moya A, Monsó E.

J Clin Microbiol. 2015 Mar;53(3):1051. doi: 10.1128/JCM.03358-14. No abstract available.

22.

Biological Marker Analysis as Part of the CIBERES-RTIC Cancer-SEPAR Strategic Project on Lung Cancer.

Monsó E, Montuenga LM, Sánchez de Cos J, Villena C; Lung Cancer CIBERES-RTICC-SEPAR-Plataforma Biobanco Pulmonar.

Arch Bronconeumol. 2015 Sep;51(9):462-7. doi: 10.1016/j.arbres.2014.11.010. Epub 2015 Jan 19. English, Spanish.

23.

Personalized respiratory medicine: exploring the horizon, addressing the issues. Summary of a BRN-AJRCCM workshop held in Barcelona on June 12, 2014.

Agustí A, Antó JM, Auffray C, Barbé F, Barreiro E, Dorca J, Escarrabill J, Faner R, Furlong LI, Garcia-Aymerich J, Gea J, Lindmark B, Monsó E, Plaza V, Puhan MA, Roca J, Ruiz-Manzano J, Sampietro-Colom L, Sanz F, Serrano L, Sharpe J, Sibila O, Silverman EK, Sterk PJ, Sznajder JI.

Am J Respir Crit Care Med. 2015 Feb 15;191(4):391-401. doi: 10.1164/rccm.201410-1935PP.

24.

Clinical audit of patients hospitalized due to COPD exacerbation. MAG-1 Study.

Escarrabill J, Torrente E, Esquinas C, Hernández C, Monsó E, Freixas M, Almagro P, Tresserras R; en nombre del equipo del Plan Director de las Enfermedades del Aparato Respiratorio (PDMAR) y del grupo colaborador del proyecto MAG-1.

Arch Bronconeumol. 2015 Oct;51(10):483-9. doi: 10.1016/j.arbres.2014.06.023. Epub 2014 Nov 3. English, Spanish.

25.

Influence of dynamic leaks in volume-targeted pressure support noninvasive ventilation: a bench study.

Luján M, Sogo A, Grimau C, Pomares X, Blanch L, Monsó E.

Respir Care. 2015 Feb;60(2):191-200. doi: 10.4187/respcare.03413. Epub 2014 Oct 14.

26.

Severity-related changes of bronchial microbiome in chronic obstructive pulmonary disease.

Garcia-Nuñez M, Millares L, Pomares X, Ferrari R, Pérez-Brocal V, Gallego M, Espasa M, Moya A, Monsó E.

J Clin Microbiol. 2014 Dec;52(12):4217-23. doi: 10.1128/JCM.01967-14. Epub 2014 Sep 24.

27.

Variability in the measurement of the methylation status of lung cancer-related genes in bronchial secretions.

Millares L, Rosell A, Setó L, Sanz J, Andreo F, Monsó E.

Oncol Rep. 2014 Oct;32(4):1435-40. doi: 10.3892/or.2014.3364. Epub 2014 Jul 28.

PMID:
25069886
28.

Determinants of false-negative results in non-small-cell lung cancer staging by endobronchial ultrasound-guided needle aspiration.

Sanz-Santos J, Serra M, Gallego M, Montón C, Cosio B, Sauleda J, Fernández-Villar A, García-Luján R, de Miguel E, Cordovilla R, Varela G, Cases E, Andreo F, Monsó E.

Eur J Cardiothorac Surg. 2015 Apr;47(4):642-7. doi: 10.1093/ejcts/ezu253. Epub 2014 Jul 8.

PMID:
25005839
29.

Pseudomonas aeruginosa isolates in severe chronic obstructive pulmonary disease: characterization and risk factors.

Gallego M, Pomares X, Espasa M, Castañer E, Solé M, Suárez D, Monsó E, Montón C.

BMC Pulm Med. 2014 Jun 26;14:103. doi: 10.1186/1471-2466-14-103.

30.

Lifetime occupational exposure to dusts, gases and fumes is associated with bronchitis symptoms and higher diffusion capacity in COPD patients.

Rodríguez E, Ferrer J, Zock JP, Serra I, Antó JM, de Batlle J, Kromhout H, Vermeulen R, Donaire-González D, Benet M, Balcells E, Monsó E, Gayete A, Garcia-Aymerich J; PAC-COPD Study Group.

PLoS One. 2014 Feb 6;9(2):e88426. doi: 10.1371/journal.pone.0088426. eCollection 2014.

31.

Bronchial microbiome of severe COPD patients colonised by Pseudomonas aeruginosa.

Millares L, Ferrari R, Gallego M, Garcia-Nuñez M, Pérez-Brocal V, Espasa M, Pomares X, Monton C, Moya A, Monsó E.

Eur J Clin Microbiol Infect Dis. 2014 Jul;33(7):1101-11. doi: 10.1007/s10096-013-2044-0. Epub 2014 Jan 22.

32.

Effect of dynamic random leaks on the monitoring accuracy of home mechanical ventilators: a bench study.

Sogo A, Montanyà J, Monsó E, Blanch L, Pomares X, Lujàn M.

BMC Pulm Med. 2013 Dec 10;13:75. doi: 10.1186/1471-2466-13-75.

33.

[Usefulness of the Chronic Obstructive Pulmonary Disease Assessment Test in chronic obstructive pulmonary disease with severe airflow limitation].

Bermudo G, Pomares X, Montón C, Baré M, Monsó E.

Med Clin (Barc). 2014 Oct 21;143(8):349-51. doi: 10.1016/j.medcli.2013.08.006. Epub 2013 Nov 7. Spanish.

PMID:
24210982
34.

Effects of immunocompromise and comorbidities on pneumococcal serotypes causing invasive respiratory infection in adults: implications for vaccine strategies.

Luján M, Burgos J, Gallego M, Falcó V, Bermudo G, Planes A, Fontanals D, Peghin M, Monsó E, Rello J.

Clin Infect Dis. 2013 Dec;57(12):1722-30. doi: 10.1093/cid/cit640. Epub 2013 Sep 24.

PMID:
24065334
35.

Specific IgA and metalloproteinase activity in bronchial secretions from stable chronic obstructive pulmonary disease patients colonized by Haemophilus influenzae.

Millares L, Marin A, Garcia-Aymerich J, Sauleda J, Belda J, Monsó E; PAC-COPD Study Group.

Respir Res. 2012 Dec 11;13:113. doi: 10.1186/1465-9921-13-113.

36.

Endobronchial ultrasound-guided transbronchial needle aspiration in the diagnosis of intrathoracic lymph node metastases from extrathoracic malignancies.

Sanz-Santos J, Cirauqui B, Sanchez E, Andreo F, Serra P, Monso E, Castellà E, Llatjós M, Mesa M, Ruiz-Manzano J, Rosell R.

Clin Exp Metastasis. 2013 Apr;30(4):521-8. doi: 10.1007/s10585-012-9556-3. Epub 2012 Nov 30.

37.

Effect of leak and breathing pattern on the accuracy of tidal volume estimation by commercial home ventilators: a bench study.

Luján M, Sogo A, Pomares X, Monsó E, Sales B, Blanch L.

Respir Care. 2013 May;58(5):770-7. doi: 10.4187/respcare.02010.

38.

Microbiome diversity in the bronchial tracts of patients with chronic obstructive pulmonary disease.

Cabrera-Rubio R, Garcia-Núñez M, Setó L, Antó JM, Moya A, Monsó E, Mira A.

J Clin Microbiol. 2012 Nov;50(11):3562-8. doi: 10.1128/JCM.00767-12. Epub 2012 Aug 22.

39.

False positive endobronchial ultrasound-guided real-time transbronchial needle aspiration secondary to bronchial carcinoma in situ at the point of puncture: a case report.

Sanz-Santos J, Andreo F, Serra P, Llatjós M, Castellà E, Astudillo J, Monsó E, Ruiz-Manzano J.

J Cardiothorac Surg. 2012 Aug 14;7:74. doi: 10.1186/1749-8090-7-74.

40.

Intra- and interobserver agreement among bronchial endosonographers for the description of intrathoracic lymph nodes.

Garcia-Olivé I, Radua J, Serra P, Andreo F, Sanz-Santos J, Monsó E, Rosell A, Cases-Viedma E, Fernández-Villar A, Núñez-Delgado M, García-Luján R, Morera J, Ruiz-Manzano J.

Ultrasound Med Biol. 2012 Jul;38(7):1163-8. doi: 10.1016/j.ultrasmedbio.2012.03.012. Epub 2012 May 12.

PMID:
22579537
41.

The role of endobronchial ultrasound in central early lung cancer.

Sanz-Santos J, Andreo F, Serra P, Monsó E, Ruiz-Manzano J.

Thorac Cancer. 2012 May;3(2):139-144. doi: 10.1111/j.1759-7714.2011.00102.x. Review.

PMID:
28920286
42.

Effect of bronchial colonisation on airway and systemic inflammation in stable COPD.

Marin A, Garcia-Aymerich J, Sauleda J, Belda J, Millares L, García-Núñez M, Serra I, Benet M, Agustí A, Antó JM, Monsó E; PAC-COPD Study Group.

COPD. 2012 Apr;9(2):121-30. doi: 10.3109/15412555.2011.636407.

PMID:
22458940
43.

Consensus document on the overlap phenotype COPD-asthma in COPD.

Soler-Cataluña JJ, Cosío B, Izquierdo JL, López-Campos JL, Marín JM, Agüero R, Baloira A, Carrizo S, Esteban C, Galdiz JB, González MC, Miravitlles M, Monsó E, Montemayor T, Morera J, Ortega F, Peces-Barba G, Puente L, Rodríguez JM, Sala E, Sauleda J, Soriano JB, Viejo JL.

Arch Bronconeumol. 2012 Sep;48(9):331-7. Epub 2012 Feb 15. English, Spanish.

44.

Contribution of cell blocks obtained through endobronchial ultrasound-guided transbronchial needle aspiration to the diagnosis of lung cancer.

Sanz-Santos J, Serra P, Andreo F, Llatjós M, Castellà E, Monsó E.

BMC Cancer. 2012 Jan 21;12:34. doi: 10.1186/1471-2407-12-34.

45.

Home mechanical ventilation monitoring software: measure more or measure better?

Luján M, Sogo A, Monsó E.

Arch Bronconeumol. 2012 May;48(5):170-8. doi: 10.1016/j.arbres.2011.10.010. Epub 2011 Dec 27. English, Spanish.

46.

Representativeness of nodal sampling with endobronchial ultrasonography in non-small-cell lung cancer staging.

Sanz-Santos J, Andreo F, Castellà E, Llatjós M, de Castro PL, Astudillo J, García-Luján R, Serra P, Monsó E.

Ultrasound Med Biol. 2012 Jan;38(1):62-8. doi: 10.1016/j.ultrasmedbio.2011.10.006.

PMID:
22137179
47.

Long-term azithromycin therapy in patients with severe COPD and repeated exacerbations.

Pomares X, Montón C, Espasa M, Casabon J, Monsó E, Gallego M.

Int J Chron Obstruct Pulmon Dis. 2011;6:449-56. doi: 10.2147/COPD.S23655. Epub 2011 Sep 6.

48.

Bronchial stump aspergillosis after lobectomy for lung cancer as an unusual cause of false positive fluorodeoxyglucose positron emission tomography and computed tomography: a case report.

Garcia-Olivé I, Andreo F, Rosiñol O, Sanz-Santos J, Font A, Monsó E.

J Med Case Rep. 2011 Feb 22;5:72. doi: 10.1186/1752-1947-5-72.

49.

Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes.

Garcia-Aymerich J, Gómez FP, Benet M, Farrero E, Basagaña X, Gayete À, Paré C, Freixa X, Ferrer J, Ferrer A, Roca J, Gáldiz JB, Sauleda J, Monsó E, Gea J, Barberà JA, Agustí À, Antó JM; PAC-COPD Study Group.

Thorax. 2011 May;66(5):430-7. doi: 10.1136/thx.2010.154484. Epub 2010 Dec 21.

50.

Anti-tissue antibodies are related to lung function in chronic obstructive pulmonary disease.

Núñez B, Sauleda J, Antó JM, Julià MR, Orozco M, Monsó E, Noguera A, Gómez FP, Garcia-Aymerich J, Agustí A; PAC-COPD Investigators.

Am J Respir Crit Care Med. 2011 Apr 15;183(8):1025-31. doi: 10.1164/rccm.201001-0029OC. Epub 2010 Nov 19.

PMID:
21097696

Supplemental Content

Support Center